Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain (Q39198311)

9 September 2017

Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain (English)

1 reference

9 September 2017

0 references

Julia Marie Raber

1

1 reference

9 September 2017

Doris Reichelt

2

1 reference

9 September 2017

Ute Grüneberg-Oelker

3

1 reference

9 September 2017

Konstanze Philipp

4

1 reference

9 September 2017

Bianca Stubbe-Dräger

5

1 reference

9 September 2017

Ingo-W Husstedt

6

1 reference

9 September 2017

25 November 2014

1 reference

9 September 2017

Acta Neurologica Belgica

1 reference

9 September 2017

115

1 reference

9 September 2017

3

1 reference

9 September 2017

335-343

1 reference

https://scigraph.springernature.com/pub.10.1007/s13760-014-0395-7

9 September 2017

0 references

cites work

Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

TRPV1 shows dynamic ionic selectivity during agonist stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Neuropathic pain and use of PainDETECT in patients with fibromyalgia: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Capsaicin 8% topical patch (Qutenza)--a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Capsaicin receptor antagonists: a promising new addition to the pain clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Acupuncture for patients with migraine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Neuropathic pain: redefinition and a grading system for clinical and research purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Placebo effects in idiopathic and neuropathic pain conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13760-014-0395-7

10.1007/S13760-014-0395-7

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference